Axon Medchem BV Offers An Exciting History Of Quality To Customers

Ryan Scientific, Inc. is proud to offer products from Axon Medchem BV, a leading European chemistry service platform. A spin-off from Axon Biochemicals BV, Axon Medchem specializes in high-quality synthesis of bio-active and/or drug-like molecules.

A Track Record Of Excellence

Axon Biochemicals BV has an excellent track record developing novel drug candidates in the CNS field and has entered into licensing agreements with international pharmaceutical companies like Astrazeneca (2006) and Lundbeck (2004). The company is actively involved in current discovery programs from pre-clinic to Phase 1. Both Axon Biochemicals BV and Axon Medchem BV operate as a contract research organization in (CRO) in medicinal chemistry.

The experienced medicinal chemists working with Axon in front-line drug research are known for their high quality chemistry services. The contract research they have done on drug design and synthesis in the diversified application fields, along with rapid synthesis of drug standards, has made the company an industry leader. Axon is concerned with "speaking the right chemistry" in specialty fine chemical fields, particularly biochemicals, neurotransmitters and drug reference standards.

Axon MedChem and Ryan Scientific Forge A Partnership

The goal at Axon Medchem BV is to extend dedicated chemistry services to pharmaceutical, biotechnology, and/or agricultural companies and research institutes around the world. Ryan Scientific, Inc. is anxious to help Axon meet this goal by making their products and services available to our customers. For more information about Axon MedChem, our newest vendor, get in touch with us today.